A consortium of academic medical centers, drugmakers and other healthcare-related organizations has created a joint initiative aimed at improving the clinical-trial-recruitment process through the use of electronic medical records.
Members of the collaborative, called Partnership to Advance Clinical electronic Research, will work to design clinical-trial-recruitment data sets that could be incorporated into electronic medical-record software. The information gleaned from the medical records could help researchers more quickly and accurately identify patients who would be appropriate candidates for experimental treatments, said PACeR participants.
PACeR's current participants include Strong Memorial Hospital of the University of Rochester (N.Y.); North Shore-Long Island Jewish Health System, Great Neck, N.Y.; drugmakers Pfizer, Johnson & Johnson and Merck & Co.; the bioethics research group the Hastings Center; and the Healthcare Association of New York State, a statewide hospital association.
"We'll be exploring how EMRs are used today to understand how, with patient consent, we can use them to enhance clinical research," David Krusch, chief medical information officer for Strong Memorial, said during a news briefing.
The first phase of the project is expected to take about seven months. During that time the group will analyze EMR data and determine which data sets and other products are needed to enhance clinical-trial recruitment and participants' care throughout the trials.